Literature DB >> 36223050

Circulating Irisin Level as a Biomarker for Pure Aortic Stenosis and Aortic Valve Calcification.

Shan-Shan Wang1, Jia-Min Li1, Po Hu1, Yu-Chao Guo1, Xian-Bao Liu1, Jian-An Wang1, Han Chen2.   

Abstract

Irisin, a myokine mainly secreted by skeletal and cardiac muscles, is actively involved in cardiovascular diseases. However, whether irisin is associated with aortic stenosis remains unknown. Two hundred ninety-three severe AS patients who underwent transcatheter aortic valve implantation were enrolled and followed-up for 35 months on average. Enzyme-linked immunosorbent assay (ELISA) was applied to measure circulating irisin levels. Patients were divided into two groups based on the median plasma irisin level. We found that high plasma irisin levels were independently associated with pure aortic stenosis (PAS) after adjusting for age, body mass index, history of peripheral vascular disease, and creatinine (OR = 3.015, 95% CI 1.775-5.119, P < 0.001). ROC curve analysis showed a significant predictive value of irisin for PAS (AUC = 0.647, 95% CI 0.583-0.711, P < 0.001). The severity of aortic valve calcification was negatively associated with plasma irisin levels (P < 0.05). In conclusion, irisin is an independent predictor for PAS and is negatively associated with the severity of aortic valve calcification.
© 2022. The Author(s).

Entities:  

Keywords:  Aortic stenosis; Biomarker; Calcification; Irisin; Transcatheter aortic valve implantation

Year:  2022        PMID: 36223050     DOI: 10.1007/s12265-022-10327-9

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   3.216


  1 in total

Review 1.  Association between irisin and major chronic diseases: a review.

Authors:  M C Gouveia; J P Vella; F R Cafeo; F L Affonso Fonseca; M R Bacci
Journal:  Eur Rev Med Pharmacol Sci       Date:  2016-10       Impact factor: 3.507

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.